Children's Hospitals and Clinics of Minnesota Receive Level III Trauma Designation
MINNEAPOLIS and ST. PAUL, Minn., July 27 /PRNewswire/ -- The Minnesota Department of Health recently designated Children's Hospitals and Clinics of Minnesota's two hospital locations as Level III Trauma Hospitals. Children's of Minnesota has the sixth busiest pediatric emergency de...Dr. Robert L. Williamson III Once Again Selected As One of America's Top Dentists
The Consumer Research Counsel of America has named Raleigh NC dentist Dr. Robert L. Williamson one of America's Top Dentists. Raleigh, North Carolina (PRWEB) July 23, 2009 -- For yet another year, Raleigh Dentist Dr. Robert L. Williamson III has received an award for ...AMA Grants New Category III CPT Code to Premier Heart's Multifunction CardioGram(TM) (MCG)
PORT WASHINGTON, N.Y., July 13 /PRNewswire/ -- Premier Heart, LLC today announced that the CPT Editorial Panel of the American Medical Association has granted a CPT Category III code to Premier Heart's Multifunction CardioGram (TM) (MCG) system. MCG is the World's first Internet based...European Division of Global Top 20 Pharmaceutical Company Awards Phase III Trial to DATATRAK
CLEVELAND, July 28 /PRNewswire-FirstCall/ -- DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that a European Division within a Global Top 20 Pharmaceutical organization has selected DA...Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
CHIPPENHAM, England and TOKYO, June 29 /PRNewswire/ -- - Study Triggers $7.5m Milestones for Both Companies Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) and Vectura Group plc ("Vectura"; LSE: VEC) announce the commencement of a Phase III clinical study by Novartis, ...ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
LEUVEN, Belgium, June 25 /PRNewswire-FirstCall/ -- - Recruitment on Track for ThromboGenics' Lead Product for the Non-Surgical Treatment of Eye Disease With No Reported Safety Issues ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and d...Streck-Lysing Agent III Lytic Reagent
Description: A lytic reagent manufactured for the simultaneous quantitative determinations of hemoglobin and white blood cells. Streck-Lysing Agent III is for use on the Abbott CELL-DYN® 1400 and 1600. The shelf life is two years from date of manufacture....Streck-Diluent III Plus Balanced Electrolyte Solution
Description: Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf life is two years from date of manufacture....Streck-Diluent III Balanced Electrolyte Solution
Description: A balanced electrolyte solution manufactured for use as a diluent for blood cell counting and sizing. Streck-Diluent III is for use on the Coulter® Counter S Plus JR, ST, JS, JT, S-Plus IV, V, VI with three-part differential and STKR, and Abbott CELL-DYN® 1400 and 1600. The shelf life is tw...Streck-Detergent III Balanced Electrolyte Solution
Description: Streck-Detergent III is a balanced electrolyte solution for use as a rinsing and hemoglobin blanking diluent. It is manufactured for the Abbott CELL-DYN® 1400, 1600, 3500 and 3700. The shelf life is two years from date of manufacture....VISULAS YAG III Combi Complete Laser Therapy System
Description: A product you can trust its capabilities will expand with your practice: perform retinal, cataract, and glaucoma therapy in one system. The VISULAS YAG III Combi is the optimal system for photocoagulation, post-cataract treatments, laser trabeculoplasty, and combined iridotomy. The push of a button...VISULAS YAG III Laser Capsulotomy Systems
Description: The VISULAS YAG III is the new disruption laser from Carl Zeiss Meditec designed in particular for applications in posterior capsulotomy (post-cataract therapy) and iridotomy. However, the YAG laser is also used for trabeculotomy, anterior capsulotomy and for IOL polishing. It's another milestone i...Phase III data show efficacy/safety of iclaprim in patients with complicated skin infections
Reinach, Switzerland, 26 October 2008 Arpida (SWX: ARPN) today presented the combined results from two pivotal Phase III clinical trials at the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America (IDSA) 46th annual meeting in Washin...Great Ape Trust to gather internationally recognized scientists for Decade of the Mind III
Des Moines, Iowa March 31, 2008 Internationally recognized research pioneers from a variety of disciplines will gather in Des Moines May 7-9 when Great Ape Trust of Iowa presents Decade of the Mind III: Emergence of the Mind, a groundbreaking symposium exploring the topics of consciousness and m...NIH announces phase III clinical trial of creatine for Parkinson's disease
The NIH National Institute of Neurological Disorders and Stroke (NINDS) today is launching a large-scale clinical trial to learn if the nutritional supplement creatine can slow the progression of Parkinson's disease (PD). While creatine is not an approved therapy for PD or any other condition, it ...Hormone levels contribute to stress resilience
... to be resilient under conditions of extreme stress, such as those regularly experienced by soldiers, police, and firefighters. Dr. Charles A. Morgan iii and his colleagues from Yale University and the VA National Center for PTSD have worked closely with collaborators at the Special Forces Underwater Wa...'Father of green chemistry' Paul Anastas to head EPA research
... New Haven, Conn. President Obama has nominated Paul Anastas, Yale's Teresa and H. John Heinz iii Professor in the Practice of Chemistry for the Environment, to lead the U.S. Environmental Protection Agency's (EPA's) Office of Research and Developm...NEWSLETTER: Antibody Fragment Production Breakthrough with 2nd Generation EBA
...field of purification of antibody fragments from an E. coli expression system. Richter-Helm BioLogics has finalized the downstream process for Phase iii clinical trial material using 2nd Generation Expanded Bed Adsorption (EBA) technology developed by the Danish biotech company Upfront Chromatography ...Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
Single-dose of investigational sustained follicle stimulant achieves similar efficacy to daily injections of follitropin beta given over a one week period in Phase III Study AMSTERDAM, July 1 /PRNewswire-FirstCall/ -- Schering-Plough Corp., (NYSE: SGP ) today announced results from the Phas...Glenmark's Novel Molecule for Diabetes, Melogliptin to Enter Phase III Trials
Release Highlights - Melogliptin continues to demonstrate potential to be the best-in-class in achieving glycemic control with low incidence of hypoglycemia and neutral effect on body weight - Global Phase III trials likely to start by end 2009 - IND approved by USFD...Diamyd(R) Phase III Study Approved for Younger Patients in the US
STOCKHOLM, June 8 /PRNewswire-FirstCall/ -- Diamyd Medical reported today that the company has received approval from the US Food and Drug Administration (FDA) to include children with type 1 diabetes from 10 years of age in the company's Phase III study with the diabetes vaccine Diamyd(R). ...D-Pharm Receives FDA Clearance to Commence a Phase III Trial of DP-b99 in Acute Stroke Patients
REHOVOT, Israel, June 8 /PRNewswire/ -- D-Pharm announced today that its Investigational New Drug (IND) application for a pivotal Phase III clinical trial of DP-b99 in acute ischemic stroke patients has been approved by the US Food and Drug Administration (FDA). D-Pharm plans to initiate the t...Hovione's TwinCaps(R) Inhaler in Phase III Clinical Trials for Influenza
LOURES, Portugal, April 15 /PRNewswire/ -- Hovione is pleased to announce that its licensee Daiichi Sankyo (Tokyo, Japan) has informed that it intends to use Hovione's TwinCaps(R) dry powder inhaler device in the launch of the compound CS-8958, an inhaled long-acting neuraminidase inhibitor ac...Mouse Anti-beta III Tubulin Monoclonal Antibody, Fluorescein Conjugated, Clone TU-20 from Abcam
Description: Mouse monoclonal [TU-20] to beta III Tubulin (FITC) ( Abpromise for all tested applications). entrezGeneID: 10381 SwissProtID: Q13509...BD Phosflow Perm Buffer III from BD Biosciences Pharmingen
Description: Perm Buffer III is intented for permeabilization following fixation of PBMCs (or lysed whole blood) for staining for intracellular kinases and appropriate CD markers simultaneously. Applications: Intracellular Staining (Flow) Storage Temperature: Room Temperature...OSMETTE III from Precision Systems, Inc.
Description: One-step High Sensitivity Freezing Point Osmometer for 10 L sample. Ideal for small volume applications, including pediatric, neonatal, geriatric, general adult, veterinary and experimental animals. Automatic Calibration with 2 or 3 user-selected values. Includes built-in printer, keypad and sof...RayBio Human Inflammation Antibody Array III & 3.1 Service from Raybiotech, Inc.
Description: Request Info...Frozen Tissue Section Panel - Monkey (Cynomolgus) Normal Tissue, Multi-tissue III from BioChain
Description: 8 different frozen tissues are mounted on positively charged glass slides...